
Yatharth Hospital (YATHARTH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.6B
Gross Profit
2.0B
79.24%
Operating Income
495.7M
19.23%
Net Income
420.4M
16.31%
EPS (Diluted)
₹4.36
Balance Sheet Metrics
Total Assets
17.3B
Total Liabilities
940.4M
Shareholders Equity
16.4B
Debt to Equity
0.06
Cash Flow Metrics
Revenue & Profitability Trend
Yatharth Hospital Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 8.8B | 6.7B | 5.2B | 4.0B | 2.3B |
Cost of Goods Sold | 3.4B | 1.3B | 929.4M | 813.3M | 463.2M |
Gross Profit | 5.4B | 5.4B | 4.3B | 3.2B | 1.8B |
Gross Margin % | 61.3% | 80.1% | 82.1% | 79.7% | 79.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 74.8M | 64.8M | 19.4M | 9.5M |
Other Operating Expenses | 3.2B | 2.3B | 1.9B | 1.2B | 657.2M |
Total Operating Expenses | 3.2B | 2.4B | 2.0B | 1.3B | 666.7M |
Operating Income | 1.6B | 1.5B | 1.1B | 841.1M | 475.0M |
Operating Margin % | 18.5% | 22.8% | 20.7% | 21.0% | 20.8% |
Non-Operating Items | |||||
Interest Income | - | 126.9M | 4.3M | 6.3M | 4.5M |
Interest Expense | 75.1M | 94.2M | 213.9M | 214.9M | 188.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.7B | 1.6B | 876.8M | 631.1M | 281.2M |
Income Tax | 411.9M | 423.6M | 219.1M | 189.4M | 85.4M |
Effective Tax Rate % | 24.0% | 27.0% | 25.0% | 30.0% | 30.4% |
Net Income | 1.3B | 1.1B | 657.7M | 441.6M | 195.9M |
Net Margin % | 14.8% | 17.1% | 12.6% | 11.0% | 8.6% |
Key Metrics | |||||
EBITDA | 2.4B | 2.0B | 1.4B | 1.1B | 675.3M |
EPS (Basic) | ₹14.72 | ₹14.46 | ₹7.66 | ₹5.14 | ₹2.12 |
EPS (Diluted) | ₹14.72 | ₹14.46 | ₹7.66 | ₹5.14 | ₹2.12 |
Basic Shares Outstanding | 88688859 | 79267355 | 85850233 | 85850233 | 85850233 |
Diluted Shares Outstanding | 88688859 | 79267355 | 85850233 | 85850233 | 85850233 |
Income Statement Trend
Yatharth Hospital Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.6B | 814.0M | 372.2M | 116.6M | 50.0M |
Short-term Investments | 1.5B | 759.4M | 10.1M | 3.7M | 1.5M |
Accounts Receivable | 3.0B | 2.3B | 1.1B | 855.4M | 367.6M |
Inventory | 209.5M | 81.3M | 60.7M | 52.0M | 33.9M |
Other Current Assets | 152.7M | -10.0K | 63.0M | 21.4M | -10.0K |
Total Current Assets | 8.6B | 5.1B | 1.8B | 1.1B | 493.2M |
Non-Current Assets | |||||
Property, Plant & Equipment | 5.0B | 123.6M | 123.6M | 123.6M | 123.6M |
Goodwill | 2.1B | 1.2B | 794.0M | 794.1M | 8.2M |
Intangible Assets | - | - | - | 70.0K | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 245.5M | -10.0K | 20.0K | -10.0K | -20.0K |
Total Non-Current Assets | 8.8B | 5.1B | 3.1B | 3.2B | 2.6B |
Total Assets | 17.3B | 10.2B | 4.9B | 4.3B | 3.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 291.4M | 291.6M | 168.8M | 204.1M | 165.3M |
Short-term Debt | 62.6M | 94.0M | 652.3M | 527.2M | 242.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 46.7M | 28.1M | 26.5M | 25.9M | 30.0M |
Total Current Liabilities | 845.8M | 672.2M | 995.2M | 971.0M | 550.0M |
Non-Current Liabilities | |||||
Long-term Debt | 53.3M | 752.5M | 2.0B | 2.1B | 1.7B |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 38.5M |
Other Non-Current Liabilities | - | - | - | -10.0K | - |
Total Non-Current Liabilities | 94.7M | 777.9M | 2.0B | 2.1B | 1.7B |
Total Liabilities | 940.4M | 1.5B | 3.0B | 3.1B | 2.3B |
Equity | |||||
Common Stock | 963.5M | 858.5M | 655.2M | 655.2M | 163.8M |
Retained Earnings | - | 2.3B | 1.2B | 511.0M | 384.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 16.4B | 8.7B | 1.8B | 1.2B | 806.8M |
Key Metrics | |||||
Total Debt | 115.9M | 846.5M | 2.7B | 2.6B | 1.9B |
Working Capital | 7.7B | 4.4B | 767.5M | 123.0M | -56.8M |
Balance Sheet Composition
Yatharth Hospital Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.7B | 1.6B | 876.8M | 631.1M | 281.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -515.6M | -1.4B | -360.2M | -407.2M | -215.8M |
Operating Cash Flow | 1.2B | 106.2M | 729.0M | 437.7M | 253.5M |
Investing Activities | |||||
Capital Expenditures | -3.1B | -933.6M | -198.1M | -131.3M | -201.4M |
Acquisitions | -925.4M | -201.1M | 0 | -389.2M | -11.3M |
Investment Purchases | -745.0M | -1.2B | -6.4M | -2.2M | -100.0K |
Investment Sales | 499.0M | - | - | - | - |
Investing Cash Flow | -4.3B | -2.4B | -204.5M | -522.8M | -212.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 6.0B | 5.8B | 0 | - | 10.0K |
Free Cash Flow | -1.6B | -964.4M | 439.7M | 468.0M | 235.4M |
Net Change in Cash | 2.9B | 3.5B | 524.5M | -85.0M | 40.8M |
Cash Flow Trend
Yatharth Hospital Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
45.87
Forward P/E
27.96
Price to Book
3.93
Price to Sales
7.41
PEG Ratio
1.98
Profitability Ratios
Profit Margin
15.35%
Operating Margin
19.23%
Return on Equity
7.97%
Return on Assets
7.54%
Financial Health
Current Ratio
10.12
Debt to Equity
0.71
Beta
0.86
Per Share Data
EPS (TTM)
₹15.53
Book Value per Share
₹181.20
Revenue per Share
₹101.44
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
yatharth | 68.7B | 45.87 | 3.93 | 7.97% | 15.35% | 0.71 |
Max Healthcare | 1.2T | 104.16 | 12.65 | 11.47% | 15.27% | 32.09 |
Apollo Hospitals | 1.1T | 71.43 | 13.69 | 16.71% | 6.98% | 90.89 |
Rainbow Children's | 157.7B | 61.73 | 10.74 | 16.50% | 16.73% | 51.77 |
Jupiter Life Line | 93.5B | 48.55 | 6.89 | 14.27% | 14.60% | 28.99 |
Healthcare Global | 92.2B | 250.42 | 9.95 | 4.49% | 1.61% | 185.57 |
Financial data is updated regularly. All figures are in the company's reporting currency.